TGTX
- TG Therapeutics, Inc.
()
Overview
Company Summary
TG Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative treatments for patients with hematologic malignancies and autoimmune diseases. Founded in 1993 and based in New York, TG Therapeutics focuses on creating therapeutic options that target specific types of cancer and autoimmune conditions.
The company's primary focus is on the research and development of small molecules and biologics, which are designed to modulate the immune system and inhibit disease progression. TG Therapeutics' drug candidates are aimed at addressing unmet medical needs and improving patient outcomes in diseases such as chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), multiple sclerosis (MS), and rheumatoid arthritis (RA).
One of the key areas of expertise for TG Therapeutics is the development of combination therapies. Their approach involves combining multiple drugs to enhance efficacy and address multiple targets for better treatment outcomes. This strategy aims to improve patient responses, reduce resistance, and optimize therapeutic benefits.
TG Therapeutics has a diverse pipeline of investigational drugs at various stages of development. Some of the lead candidates include umbralisib, a PI3K delta inhibitor, and ublituximab, a novel monoclonal antibody. These drugs are being evaluated as potential treatment options for several hematologic malignancies and autoimmune diseases.
In addition to drug development, TG Therapeutics is also engaged in clinical trials and research collaborations with other pharmaceutical companies, academic institutions, and medical organizations. These partnerships help to advance their understanding of disease biology, expand their drug portfolio, and gain access to additional resources and expertise.
Overall, TG Therapeutics, Inc. is dedicated to improving the lives of patients with hematologic malignancies and autoimmune diseases by developing novel therapies that target specific disease pathways and modulate the immune system.